Daniel Faga - 06 Jan 2026 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jan 2026, 16:10:16 UTC
Prior SEC filing
06 Jan 2026
Next SEC filing
09 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Loumeau, Attorney-in-Fact

Key filing fact

Daniel Faga filed Form 4 for ANAPTYSBIO, INC (ANAB) on 08 Jan 2026.

Key facts

  • This page summarizes Daniel Faga's Form 4 filing for ANAPTYSBIO, INC (ANAB).
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Jan 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 06 Jan 2026.
  • Current net transaction value: -$415,102.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673528 Primary reporting owner

Faga Daniel

Relationship
President, CEO, Director
Address
C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Signature date
08 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANAB transaction

Common Stock

Options Exercise

Transaction value
Shares
+17,850
Change %
+3.9%
Price
Shares after
475,989
Date
06 Jan 2026
Ownership
Direct
Footnotes
F1
ANAB transaction

Common Stock

Sale

Transaction value
$415,102
Shares
-9,202
Change %
-1.9%
Price
$45.11
Shares after
466,787
Date
07 Jan 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANAB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-17,850
Change %
-50%
Price
$0.000000
Shares after
17,850
Date
06 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,850
Exercise price
Footnotes
F1, F3
ANAB transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+98,600
Change %
Price
$0.000000
Shares after
98,600
Date
06 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
98,600
Exercise price
Footnotes
F1, F4
ANAB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+133,400
Change %
Price
$0.000000
Shares after
133,400
Date
06 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
133,400
Exercise price
$43.91
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Footnote F4

The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Footnote F5

The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .